针对艾滋病护理领域药剂师的基于人工智能的聊天机器人的需求评估：知识-态度-实践调查结果

Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge-Attitudes-Practices Survey.

作者信息

Laymouna Moustafa, Ma Yuanchao, Lessard David, Engler Kim, Therrien Rachel, Schuster Tibor, Vicente Serge, Achiche Sofiane, El Haj Maria Nait, Lemire Benoît, Kawaiah Abdalwahab, Lebouché Bertrand

机构信息

Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3S 1Z1, Canada.

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3S5, Canada.

出版信息

Healthcare (Basel). 2024 Aug 20;12(16):1661. doi: 10.3390/healthcare12161661.

DOI:10.3390/healthcare12161661

PMID:39201222

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11353819/

Abstract

BACKGROUND

Pharmacists need up-to-date knowledge and decision-making support in HIV care. We aim to develop MARVIN-Pharma, an adapted artificial intelligence-based chatbot initially for people with HIV, to assist pharmacists in considering evidence-based needs.

METHODS

From December 2022 to December 2023, an online needs-assessment survey evaluated Québec pharmacists' knowledge, attitudes, involvement, and barriers relative to HIV care, alongside perceptions relevant to the usability of MARVIN-Pharma. Recruitment involved convenience and snowball sampling, targeting National HIV and Hepatitis Mentoring Program affiliates.

RESULTS

Forty-one pharmacists (28 community, 13 hospital-based) across 15 Québec municipalities participated. Participants perceived their HIV knowledge as moderate (M = 3.74/6). They held largely favorable attitudes towards providing HIV care (M = 4.02/6). They reported a "little" involvement in the delivery of HIV care services (M = 2.08/5), most often ART adherence counseling, refilling, and monitoring. The most common barriers reported to HIV care delivery were a lack of time, staff resources, clinical tools, and HIV information/training, with pharmacists at least somewhat agreeing that they experienced each (M ≥ 4.00/6). On average, MARVIN-Pharma's acceptability and compatibility were in the 'undecided' range (M = 4.34, M = 4.13/7, respectively), while pharmacists agreed to their self-efficacy to use online health services (M = 5.6/7).

CONCLUSION

MARVIN-Pharma might help address pharmacists' knowledge gaps and barriers to HIV treatment and care, but pharmacist engagement in the chatbot's development seems vital for its future uptake and usability.

摘要

背景

药剂师在艾滋病护理方面需要最新的知识和决策支持。我们旨在开发MARVIN-Pharma，这是一种经过改编的基于人工智能的聊天机器人，最初面向艾滋病患者，以协助药剂师考虑基于证据的需求。

方法

2022年12月至2023年12月，一项在线需求评估调查评估了魁北克药剂师在艾滋病护理方面的知识、态度、参与情况和障碍，以及与MARVIN-Pharma可用性相关的看法。招募采用便利抽样和滚雪球抽样，目标是国家艾滋病和肝炎指导计划的附属机构。

结果

魁北克15个城市的41名药剂师（28名社区药剂师，13名医院药剂师）参与了调查。参与者认为他们的艾滋病知识处于中等水平（M = 3.74/6）。他们对提供艾滋病护理持基本积极的态度（M = 4.02/6）。他们表示在艾滋病护理服务的提供方面“参与度较低”（M = 2.08/5），最常见的是抗逆转录病毒治疗依从性咨询、配药和监测。报告的艾滋病护理提供的最常见障碍是缺乏时间、人员资源、临床工具以及艾滋病信息/培训，药剂师至少在一定程度上认同他们经历过这些障碍（M≥4.00/6）。平均而言，MARVIN-Pharma的可接受性和兼容性处于“未决定”范围（分别为M = 4.34，M = 4.13/7），而药剂师认同他们使用在线健康服务的自我效能感（M = 5.6/7）。